2013 Form 10-K Financial Statement
#000119312514045903 Filed on February 12, 2014
Income Statement
Concept | 2013 | 2012 Q4 | 2012 Q3 |
---|---|---|---|
Revenue | $2.154B | $471.3M | $473.1M |
YoY Change | 18.57% | 16.4% | 16.04% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.580B | $340.9M | $340.2M |
YoY Change | 19.25% | 18.62% | 17.43% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $39.97M | $8.091M | $7.925M |
YoY Change | 29.69% | 11.35% | 27.56% |
% of Gross Profit | |||
Operating Expenses | $1.702B | $368.3M | $365.8M |
YoY Change | 19.26% | 17.52% | 17.0% |
Operating Profit | $452.1M | $103.0M | $107.4M |
YoY Change | 16.07% | 12.58% | 12.98% |
Interest Expense | $5.415M | $1.219M | $624.0K |
YoY Change | 66.87% | 78.22% | -40.91% |
% of Operating Profit | 1.2% | 1.18% | 0.58% |
Other Income/Expense, Net | -$3.719M | ||
YoY Change | 175.69% | ||
Pretax Income | $448.4M | $102.5M | $107.2M |
YoY Change | 15.52% | 12.22% | 13.63% |
Income Tax | $167.9M | $36.38M | $41.26M |
% Of Pretax Income | 37.44% | 35.5% | 38.5% |
Net Earnings | $280.5M | $66.10M | $65.91M |
YoY Change | 16.44% | 13.27% | 13.17% |
Net Earnings / Revenue | 13.02% | 14.03% | 13.93% |
Basic Earnings Per Share | $2.83 | $0.67 | $0.67 |
Diluted Earnings Per Share | $2.78 | $0.66 | $0.66 |
COMMON SHARES | |||
Basic Shares Outstanding | 99.11M shares | 98.23M shares | 97.88M shares |
Diluted Shares Outstanding | 101.0M shares | 100.2M shares | 99.62M shares |
Balance Sheet
Concept | 2013 | 2012 Q4 | 2012 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $37.60M | $27.90M | $71.90M |
YoY Change | 34.77% | 22.91% | 67.21% |
Cash & Equivalents | $31.10M | $21.28M | $66.12M |
Short-Term Investments | $6.500M | $6.600M | $5.800M |
Other Short-Term Assets | $45.20M | $9.228M | $6.898M |
YoY Change | -45.67% | 22.53% | -91.79% |
Inventory | |||
Prepaid Expenses | $4.852M | $5.149M | |
Receivables | $285.4M | $248.1M | $250.5M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $368.1M | $359.0M | $402.8M |
YoY Change | 2.53% | 6.46% | 20.6% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $59.90M | $59.74M | $59.21M |
YoY Change | 0.34% | -1.31% | -3.88% |
Goodwill | $2.166B | $1.940B | |
YoY Change | 23.98% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $57.50M | $47.60M | $40.50M |
YoY Change | 20.8% | 5.78% | 15.71% |
Other Assets | $129.4M | $118.3M | $90.67M |
YoY Change | 553.54% | 42.36% | 37.8% |
Total Long-Term Assets | $2.641B | $2.391B | $2.130B |
YoY Change | 10.43% | 23.56% | 15.41% |
TOTAL ASSETS | |||
Total Short-Term Assets | $368.1M | $359.0M | $402.8M |
Total Long-Term Assets | $2.641B | $2.391B | $2.130B |
Total Assets | $3.009B | $2.750B | $2.533B |
YoY Change | 9.4% | 21.02% | 16.2% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $18.60M | $13.81M | $9.970M |
YoY Change | 34.78% | 12.62% | 1.73% |
Accrued Expenses | $290.1M | $241.8M | $214.9M |
YoY Change | 19.98% | 8.77% | 12.99% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $100.0K | $100.0K | $100.0K |
YoY Change | 0.0% | 0.0% | -50.0% |
Total Short-Term Liabilities | $326.8M | $268.3M | $244.9M |
YoY Change | 21.8% | 5.52% | 13.85% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $27.10M | $144.2M | $48.30M |
YoY Change | -81.21% | 392.15% | -4.17% |
Other Long-Term Liabilities | $200.4M | $56.95M | $55.86M |
YoY Change | 13.54% | 4.41% | -65.79% |
Total Long-Term Liabilities | $227.5M | $56.95M | $55.86M |
YoY Change | -29.06% | 4.41% | -73.86% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $326.8M | $268.3M | $244.9M |
Total Long-Term Liabilities | $227.5M | $56.95M | $55.86M |
Total Liabilities | $665.7M | $715.0M | $583.9M |
YoY Change | -6.9% | 32.0% | 12.8% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $1.247B | $1.181B | |
YoY Change | 23.95% | ||
Common Stock | $1.000M | $498.0K | |
YoY Change | 104.5% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.343B | $2.035B | $1.949B |
YoY Change | |||
Total Liabilities & Shareholders Equity | $3.009B | $2.750B | $2.533B |
YoY Change | 9.4% | 21.02% | 16.2% |
Cashflow Statement
Concept | 2013 | 2012 Q4 | 2012 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $280.5M | $66.10M | $65.91M |
YoY Change | 16.44% | 13.27% | 13.17% |
Depreciation, Depletion And Amortization | $39.97M | $8.091M | $7.925M |
YoY Change | 29.69% | 11.35% | 27.56% |
Cash From Operating Activities | $405.4M | $105.2M | $134.7M |
YoY Change | 24.77% | 17.15% | 34.57% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$15.70M | -$4.600M | -$3.100M |
YoY Change | 8.28% | 70.37% | -40.38% |
Acquisitions | $238.0M | ||
YoY Change | -46.02% | ||
Other Investing Activities | -$247.8M | -$246.6M | -$131.3M |
YoY Change | -44.45% | 201.47% | 77.43% |
Cash From Investing Activities | -$263.5M | -$251.1M | -$134.4M |
YoY Change | -42.79% | 196.81% | 69.7% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $23.17M | ||
YoY Change | -180.41% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -132.1M | 101.1M | 53.70M |
YoY Change | -195.46% | -551.34% | -690.11% |
NET CHANGE | |||
Cash From Operating Activities | 405.4M | 105.2M | 134.7M |
Cash From Investing Activities | -263.5M | -251.1M | -134.4M |
Cash From Financing Activities | -132.1M | 101.1M | 53.70M |
Net Change In Cash | 9.857M | -44.80M | 54.00M |
YoY Change | 267.25% | 160.47% | 357.63% |
FREE CASH FLOW | |||
Cash From Operating Activities | $405.4M | $105.2M | $134.7M |
Capital Expenditures | -$15.70M | -$4.600M | -$3.100M |
Free Cash Flow | $421.1M | $109.8M | $137.8M |
YoY Change | 24.07% | 18.7% | 30.86% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
101265594 | shares |
CY2012Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
169799000 | |
CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
30.97 | |
CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
4551139349 | |
CY2010Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
22290000 | |
CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1447454000 | |
CY2010Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
|
111662000 | |
CY2010Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
421977000 | |
CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
26251000 | |
CY2011Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
16165000 | |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1731016000 | |
CY2011Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
|
122847000 | |
CY2011Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
576030000 | |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18596000 | |
CY2011Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9400000 | |
CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
100038000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
101207000 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1961796 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
23.51 | |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3039288 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2012Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
101000 | |
CY2012Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
9000000 | |
CY2012Q4 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
90600000 | |
CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
74051000 | |
CY2012Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
11603000 | |
CY2012Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
|
17466000 | |
CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
787580000 | |
CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
13812000 | |
CY2012Q4 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
36176000 | |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
268338000 | |
CY2012Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
13072000 | |
CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
160495000 | |
CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
56951000 | |
CY2012Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
233000 | |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2035368000 | |
CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
624896000 | |
CY2012Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
14700000 | |
CY2012Q4 | us-gaap |
Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
|
22100000 | |
CY2012Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
|
119570000 | |
CY2012Q4 | us-gaap |
Long Term Line Of Credit
LongTermLineOfCredit
|
144000000 | |
CY2012Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
255661000 | |
CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
1246788000 | |
CY2012Q4 | us-gaap |
Assets
Assets
|
2750337000 | |
CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
46300000 | |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000000 | |
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2750337000 | |
CY2012Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
125877000 | |
CY2012Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
|
12000000 | |
CY2012Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
12576000 | |
CY2012Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
334000 | |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
714969000 | |
CY2012Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
|
137036000 | |
CY2012Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
624896000 | |
CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
359044000 | |
CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
2165672000 | |
CY2012Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
19787000 | |
CY2012Q4 | us-gaap |
Fixtures And Equipment Gross
FixturesAndEquipmentGross
|
104149000 | |
CY2012Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
|
48200000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
18444000 | |
CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
118290000 | |
CY2012Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
4852000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5624000 | |
CY2012Q4 | us-gaap |
Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
|
13800000 | |
CY2012Q4 | us-gaap |
Land
Land
|
6683000 | |
CY2012Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
98503000 | |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
21280000 | |
CY2012Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
872962000 | |
CY2012Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
22957000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-56843000 | |
CY2012Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
11100000 | |
CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
248066000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
43345000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
802000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
112956000 | |
CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
133789000 | |
CY2012Q4 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
47593000 | |
CY2012Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
14900000 | |
CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
144800000 | |
CY2012Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
9228000 | |
CY2012Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
6584000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
69034000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
509000 | |
CY2012Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
44232000 | |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
37.78 | |
CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2013Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
92000 | |
CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
59738000 | |
CY2012Q4 | md |
Deferred Tax Liabilities Amortization
DeferredTaxLiabilitiesAmortization
|
136670000 | |
CY2012Q4 | md |
Accrued Professional Liability
AccruedProfessionalLiability
|
46400000 | |
CY2012Q4 | md |
Deferred Tax Liabilities Accrual To Cash Adjustment
DeferredTaxLiabilitiesAccrualToCashAdjustment
|
33129000 | |
CY2012Q4 | md |
Accrued Contingent Consideration Liability
AccruedContingentConsiderationLiability
|
16109000 | |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
100038000 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1941330 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
101207000 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1519976 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
26.74 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1966170 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
7300000 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2013Q4 | us-gaap |
Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
|
0.009 | pure |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
26.62 | |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
18989000 | |
CY2013Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
8400000 | |
CY2013Q4 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
110300000 | |
CY2013Q4 | us-gaap |
Business Combination Contingent Consideration Arrangements Range Of Outcomes Value Low
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
|
0 | |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
86999000 | |
CY2013Q4 | us-gaap |
Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
|
100000 | |
CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
18150000 | |
CY2013Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
|
19324000 | |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
857953000 | |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
83047000 | |
CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
18605000 | |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
9843000 | |
CY2013Q4 | us-gaap |
Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
|
43403000 | |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
326792000 | |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
9398000 | |
CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
14902000 | |
CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
189439000 | |
CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
60985000 | |
CY2013Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
143000 | |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2342988000 | |
CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
712285000 | |
CY2013Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
13400000 | |
CY2013Q4 | us-gaap |
Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
|
23300000 | |
CY2013Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
|
139367000 | |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
6198000 | |
CY2013Q4 | us-gaap |
Long Term Line Of Credit
LongTermLineOfCredit
|
27000000 | |
CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
308754000 | |
CY2013Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
767700000 | |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
1484023000 | |
CY2013Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
200217000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
70800000 | |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1012000 | |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3049430000 | |
CY2013Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
152155000 | |
CY2013Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
|
100000 | |
CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
|
8100000 | |
CY2013Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
17946000 | |
CY2013Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
235000 | |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
706442000 | |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
14098000 | |
CY2013Q4 | us-gaap |
Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
|
158691000 | |
CY2013Q4 | us-gaap |
Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
|
14600000 | |
CY2013Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
712285000 | |
CY2013Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
14500000 | |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
24521000 | |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
408839000 | |
CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
2393731000 | |
CY2013Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
25799000 | |
CY2013Q4 | us-gaap |
Fixtures And Equipment Gross
FixturesAndEquipmentGross
|
117246000 | |
CY2013Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
|
29600000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
16457000 | |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
129438000 | |
CY2013Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
6361000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6385000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
25400000 | |
CY2013Q4 | us-gaap |
Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
|
17100000 | |
CY2013Q4 | us-gaap |
Land
Land
|
6683000 | |
CY2013Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
103639000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
8600000 | |
CY2013Q4 | us-gaap |
Assets
Assets
|
3049430000 | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
31137000 | |
CY2013Q4 | md |
Line Of Credit Facility Potential Increase In Borrowing Capacity
LineOfCreditFacilityPotentialIncreaseInBorrowingCapacity
|
1000000000 | |
CY2013Q4 | md |
Deferred Tax Liabilities Accrual To Cash Adjustment
DeferredTaxLiabilitiesAccrualToCashAdjustment
|
37818000 | |
CY2013Q4 | md |
Line Of Credit Facility Reduction In Available Balance
LineOfCreditFacilityReductionInAvailableBalance
|
5300000 | |
CY2013Q4 | md |
Accrued Contingent Consideration Liability
AccruedContingentConsiderationLiability
|
19833000 | |
CY2013Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
2 | pure |
CY2013Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
119542000 | |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
146910000 | |
CY2013Q4 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
57511000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
23800000 | |
CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
51900000 | |
CY2013Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
16900000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
174400000 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
52400000 | |
CY2013Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
997682000 | |
CY2013Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
22981000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
-80675000 | |
CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
26300000 | |
CY2013Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
5300000 | |
CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
285397000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
20800000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
52519000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
1310000 | |
CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
8007000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
15500000 | |
CY2013Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
6457000 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
9500000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
71480000 | |
CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
33000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
446000 | |
CY2013Q4 | us-gaap |
Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
|
111000000 | |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
42425000 | |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
59911000 | |
CY2013Q4 | md |
Deferred Tax Liabilities Amortization
DeferredTaxLiabilitiesAmortization
|
162399000 | |
CY2013Q4 | md |
Accrued Professional Liability
AccruedProfessionalLiability
|
48400000 | |
CY2011 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.23 | |
CY2011 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
97592000 | shares |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3500 | pure |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0044 | pure |
CY2011 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.28 | |
CY2011 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.3829 | pure |
CY2011 | us-gaap |
Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
|
9843000 | |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0032 | pure |
CY2011 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
90000 | shares |
CY2011 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
31362000 | |
CY2011 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2569000 | |
CY2011 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
44000 | |
CY2011 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
3433000 | |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.0013 | pure |
CY2011 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
2180000 | shares |
CY2011 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
270669000 | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
35.50 | |
CY2011 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
95412000 | shares |
CY2011 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0266 | pure |
CY2011 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
2541000 | |
CY2011 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
-3208028000 | |
CY2011 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
751000 | |
CY2011 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
119261000 | |
CY2011 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
154885000 | |
CY2011 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
630000000 | |
CY2011 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
7100000 | |
CY2011 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-3932000 | |
CY2011 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
31332000 | |
CY2011 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
3362081000 | |
CY2011 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
355389000 | |
CY2011 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
42526000 | |
CY2011 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
353245000 | |
CY2011 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
48993000 | |
CY2011 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1495000 | |
CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
217997000 | |
CY2011 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
463000 | |
CY2011 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
1588248000 | |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
27092000 | |
CY2011 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
||
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
7111000 | |
CY2011 | us-gaap |
Malpractice Loss Contingency Claims Incurred In Prior Periods
MalpracticeLossContingencyClaimsIncurredInPriorPeriods
|
11526000 | |
CY2011 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
21480000 | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
19000000 | |
CY2011 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
20300000 | |
CY2011 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
170356000 | |
CY2011 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-87751000 | |
CY2011 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
38170000 | |
CY2011 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
14472000 | |
CY2011 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
||
CY2011 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
8063000 | |
CY2011 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
14100000 | |
CY2011 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
11747000 | |
CY2011 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
27092000 | |
CY2011 | us-gaap |
Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
|
24500000 | |
CY2011 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-7655000 | |
CY2011 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
13895000 | |
CY2011 | us-gaap |
Interest Expense
InterestExpense
|
3639000 | |
CY2011 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
6704000 | |
CY2011 | us-gaap |
Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
|
221000 | |
CY2011 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
31362000 | |
CY2011 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
7486000 | |
CY2011 | md |
Line Of Credit Facility Payments For Amendment
LineOfCreditFacilityPaymentsForAmendment
|
1970000 | |
CY2011 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
135248000 | |
CY2011 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-190573000 | |
CY2011 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
|
7203000 | |
CY2011 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1959000 | |
CY2011 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
512500000 | |
CY2011 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
577000 | |
CY2011 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
25292000 | |
CY2011 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
120776000 | |
CY2011 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
7031000 | |
CY2011 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
13000 | |
CY2011 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10300000 | |
CY2011 | us-gaap |
Depreciation
Depreciation
|
15000000 | |
CY2011 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
27100000 | |
CY2011 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
20800000 | |
CY2011 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
970396000 | |
CY2011 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
1520000 | |
CY2011 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
113290000 | |
CY2011 | us-gaap |
Operating Expenses
OperatingExpenses
|
1232859000 | |
CY2011 | us-gaap |
Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
|
400000 | |
CY2011 | md |
Provision Adjustment For Losses Related To Current Year
ProvisionAdjustmentForLossesRelatedToCurrentYear
|
33031000 | |
CY2011 | md |
Health Care Organization Patient Service Revenue Gross
HealthCareOrganizationPatientServiceRevenueGross
|
4851500000 | |
CY2011 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
66815000 | |
CY2011 | md |
Hospital Contract Administrative Fees
HospitalContractAdministrativeFees
|
98829000 | |
CY2011 | md |
Payment Of Contingent Consideration Liability
PaymentOfContingentConsiderationLiability
|
350000 | |
CY2011 | md |
Provision Adjustment For Losses Related To Prior Year
ProvisionAdjustmentForLossesRelatedToPriorYear
|
-10099000 | |
CY2011 | md |
Payments Of Contingent Consideration Liabilities
PaymentsOfContingentConsiderationLiabilities
|
6211000 | |
CY2011 | md |
Contractual Adjustments And Uncollectibles
ContractualAdjustmentsAndUncollectibles
|
3362081000 | |
CY2011 | md |
Net Change In Fair Value Of Contingent Consideration Liabilities
NetChangeInFairValueOfContingentConsiderationLiabilities
|
1083000 | |
CY2011 | md |
Malpractice Loss Contingency Provision For Losses
MalpracticeLossContingencyProvisionForLosses
|
22932000 | |
CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
MEDNAX, INC. | |
CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
CY2013 | dei |
Document Type
DocumentType
|
10-K | |
CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000893949 | |
CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
Yes | |
CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
27666 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
634882 | shares |
CY2013 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.78 | |
CY2013 | us-gaap |
Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
|
99112000 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
100969000 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
35.37 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3500 | pure |
CY2013 | us-gaap |
Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
|
100969000 | shares |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.0048 | pure |
CY2013 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.83 | |
CY2013 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1.     General:</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The principal business activity of MEDNAX, Inc. (“MEDNAX” or the “Company”) and its subsidiaries is to provide neonatal, anesthesia, maternal-fetal and other pediatric subspecialties physician services. The Company has contracts with affiliated professional associations, corporations and partnerships (“affiliated professional contractors”), which are separate legal entities that provide physician services in certain states and Puerto Rico. The Company and its affiliated professional contractors also have contracts with hospitals and other healthcare facilities to provide physician services, which include (i) fee-for-service contracts, whereby hospitals agree, in exchange for the Company’s services, to authorize the Company and its healthcare professionals to bill and collect the charges for medical services rendered by the Company’s affiliated healthcare professionals, and (ii) administrative fee contracts, whereby the Company is assured a minimum revenue level.</font></p> </div> | |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y | |
CY2013 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
2.90 | |
CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.3744 | pure |
CY2013 | us-gaap |
Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
|
19797000 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
31.77 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0027 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.0002 | pure |
CY2013 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1857000 | shares |
CY2013 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
|
2.85 | |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
405398000 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
17.58 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
46.48 | |
CY2013 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y4M24D | |
CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99112000 | shares |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y | |
CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1073118 | shares |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0263 | pure |
CY2013 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
1100000 | shares |
CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
35000 | shares |
CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Accounting Estimates and Assumptions</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions are involved in the calculation of the Company’s allowance for contractual adjustments and uncollectibles on accounts receivable, liabilities for self-insured amounts and claims incurred but not reported related to the Company’s professional liability risks, the fair value of goodwill, and liabilities for uncertain tax positions. Actual results could differ from those estimates.</font></p> </div> | |
CY2013 | us-gaap |
Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
|
228100000 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
1049036 | shares |
CY2013 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P1Y7M6D | |
CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
28697000 | |
CY2013 | us-gaap |
Interest Paid Net
InterestPaidNet
|
3312000 | |
CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
338000 | |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-212000 | |
CY2013 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
250100000 | |
CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
2955000 | |
CY2013 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
-4607843000 | |
CY2013 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
||
CY2013 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
126411000 | |
CY2013 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
236700000 | |
CY2013 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
238045000 | |
CY2013 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
1028500000 | |
CY2013 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
19000000 | |
CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
3541000 | |
CY2013 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
15654000 | |
CY2013 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
4695232000 | |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
452131000 | |
CY2013 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
287918000 | |
CY2013 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
2235170000 | |
CY2013 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
20802000 | |
CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
448412000 | |
CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
37331000 | |
CY2013 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1696000 | |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
280517000 | |
CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
99000 | |
CY2013 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
2154012000 | |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
31288000 | |
CY2013 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
51863000 | |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
18981000 | |
CY2013 | us-gaap |
Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
|
600000 | |
CY2013 | us-gaap |
Malpractice Loss Contingency Claims Incurred In Prior Periods
MalpracticeLossContingencyClaimsIncurredInPriorPeriods
|
10739000 | |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
49239000 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
33300000 | |
CY2013 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
29800000 | |
CY2013 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
38000 | |
CY2013 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
28900000 | |
CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
218209000 | |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-132051000 | |
CY2013 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
43000000 | |
CY2013 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
11011000 | |
CY2013 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
18173000 | |
CY2013 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
||
CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
15920000 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
35400000 | |
CY2013 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
11480000 | |
CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
31288000 | |
CY2013 | us-gaap |
Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
|
18900000 | |
CY2013 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
51863000 | |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
9857000 | |
CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
17037000 | |
CY2013 | us-gaap |
Interest Expense
InterestExpense
|
5415000 | |
CY2013 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
5772000 | |
CY2013 | us-gaap |
Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
|
741000 | |
CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
28697000 | |
CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
14784000 | |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-263490000 | |
CY2013 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1211000 | |
CY2013 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
911500000 | |
CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
1136000 | |
CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
39966000 | |
CY2013 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
149722000 | |
CY2013 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
18579000 | |
CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
24500000 | |
CY2013 | us-gaap |
Depreciation
Depreciation
|
15500000 | |
CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
31300000 | |
CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
26400000 | |
CY2013 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1361318000 | |
CY2013 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
1425000 | |
CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
134938000 | |
CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
1701881000 | |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
167895000 | |
CY2013 | md |
Line Of Credit Facility Payments For Amendment
LineOfCreditFacilityPaymentsForAmendment
|
||
CY2013 | md |
Number Of Physician Group Practices
NumberOfPhysicianGroupPractices
|
11 | Company |
CY2013 | md |
Business Acquisition Contingent Consideration At Fair Value Increase Decrease
BusinessAcquisitionContingentConsiderationAtFairValueIncreaseDecrease
|
1800000 | |
CY2013 | md |
Long Term Investment Maturity Minimum
LongTermInvestmentMaturityMinimum
|
P1Y | |
CY2013 | md |
Provision Adjustment For Losses Related To Current Year
ProvisionAdjustmentForLossesRelatedToCurrentYear
|
41235000 | |
CY2013 | md |
Health Care Organization Patient Service Revenue Gross
HealthCareOrganizationPatientServiceRevenueGross
|
6702484000 | |
CY2013 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
82388000 | |
CY2013 | md |
Increase In Uncertain Tax Position
IncreaseInUncertainTaxPosition
|
1800000 | |
CY2013 | md |
Hospital Contract Administrative Fees
HospitalContractAdministrativeFees
|
146760000 | |
CY2013 | md |
Time Period For Achievement Of Certain Performance Measures For Payment Of Contingent Consideration
TimePeriodForAchievementOfCertainPerformanceMeasuresForPaymentOfContingentConsideration
|
P5Y | |
CY2013 | md |
Payment Of Contingent Consideration Liability
PaymentOfContingentConsiderationLiability
|
1308000 | |
CY2013 | md |
Long Term Investment Maturity Maximum
LongTermInvestmentMaturityMaximum
|
P7Y | |
CY2013 | md |
Business Combination Contingent Consideration Arrangements Time Period
BusinessCombinationContingentConsiderationArrangementsTimePeriod
|
P5Y | |
CY2013 | md |
Assumed Payment Probability Of Contingent Consideration Payment
AssumedPaymentProbabilityOfContingentConsiderationPayment
|
1.00 | pure |
CY2013 | md |
Net Operating Loss Carry Forwards Expiration Date
NetOperatingLossCarryForwardsExpirationDate
|
2019 | |
CY2013 | md |
Provision Adjustment For Losses Related To Prior Year
ProvisionAdjustmentForLossesRelatedToPriorYear
|
-8100000 | |
CY2013 | md |
Payments Of Contingent Consideration Liabilities
PaymentsOfContingentConsiderationLiabilities
|
10365000 | |
CY2013 | md |
Contingent Consideration Payments Related To Prior Period Acquisitions
ContingentConsiderationPaymentsRelatedToPriorPeriodAcquisitions
|
13400000 | |
CY2013 | md |
Contractual Adjustments And Uncollectibles
ContractualAdjustmentsAndUncollectibles
|
4695232000 | |
CY2013 | md |
Net Change In Fair Value Of Contingent Consideration Liabilities
NetChangeInFairValueOfContingentConsiderationLiabilities
|
3656000 | |
CY2013 | md |
Business Acquisition Contingent Consideration At Fair Value Decrease
BusinessAcquisitionContingentConsiderationAtFairValueDecrease
|
900000 | |
CY2013 | md |
Business Acquisition Contingent Consideration At Fair Value Increase
BusinessAcquisitionContingentConsiderationAtFairValueIncrease
|
2700000 | |
CY2013 | md |
Malpractice Loss Contingency Provision For Losses
MalpracticeLossContingencyProvisionForLosses
|
33135000 | |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
0.3794 | pure |
CY2012 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.42 | |
CY2012 | us-gaap |
Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
|
97386000 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99382000 | shares |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3500 | pure |
CY2012 | us-gaap |
Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
|
99382000 | shares |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.0015 | pure |
CY2012 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.47 | |
CY2012 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
2.80 | |
CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.3794 | pure |
CY2012 | us-gaap |
Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
|
9941000 | |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.0036 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.0013 | pure |
CY2012 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1996000 | shares |
CY2012 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
|
2.74 | |
CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
324906000 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
30.06 | |
CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
97386000 | shares |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0260 | pure |
CY2012 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
58000 | shares |
CY2012 | us-gaap |
Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
|
418900000 | |
CY2012 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
28810000 | |
CY2012 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2044000 | |
CY2012 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
102000 | |
CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
244000 | |
CY2012 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
451100000 | |
CY2012 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
2478000 | |
CY2012 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
-3946058000 | |
CY2012 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
||
CY2012 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
129636000 | |
CY2012 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
436400000 | |
CY2012 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
441006000 | |
CY2012 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
402500000 | |
CY2012 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
6200000 | |
CY2012 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-1153000 | |
CY2012 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
14495000 | |
CY2012 | us-gaap |
Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
|
3994924000 | |
CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
389520000 | |
CY2012 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
272657000 | |
CY2012 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
2165561000 | |
CY2012 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
33120000 | |
CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
388171000 | |
CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
17678000 | |
CY2012 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1896000 | |
CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
240907000 | |
CY2012 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
136000 | |
CY2012 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
1816612000 | |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
28437000 | |
CY2012 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
||
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
6198000 | |
CY2012 | us-gaap |
Malpractice Loss Contingency Claims Incurred In Prior Periods
MalpracticeLossContingencyClaimsIncurredInPriorPeriods
|
12564000 | |
CY2012 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
16953000 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
23000000 | |
CY2012 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
24800000 | |
CY2012 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
193540000 | |
CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
138326000 | |
CY2012 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
37700000 | |
CY2012 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
28073000 | |
CY2012 | us-gaap |
State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
|
15510000 | |
CY2012 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
||
CY2012 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
21344000 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
18100000 | |
CY2012 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
13133000 | |
CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28437000 | |
CY2012 | us-gaap |
Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
|
20800000 | |
CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2684000 | |
CY2012 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
13980000 | |
CY2012 | us-gaap |
Interest Expense
InterestExpense
|
3245000 | |
CY2012 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-7343000 | |
CY2012 | us-gaap |
Malpractice Loss Contingency Claims Incurred In Period
MalpracticeLossContingencyClaimsIncurredInPeriod
|
569000 | |
CY2012 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
28810000 | |
CY2012 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
19814000 | |
CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-460548000 | |
CY2012 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
|
3671000 | |
CY2012 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
411000 | |
CY2012 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
517500000 | |
CY2012 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
1530000 | |
CY2012 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
30816000 | |
CY2012 | us-gaap |
Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
|
131754000 | |
CY2012 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
6494000 | |
CY2012 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
15000000 | |
CY2012 | us-gaap |
Depreciation
Depreciation
|
15800000 | |
CY2012 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
28400000 | |
CY2012 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
23900000 | |
CY2012 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1130913000 | |
CY2012 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
2002000 | |
CY2012 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
111940000 | |
CY2012 | us-gaap |
Operating Expenses
OperatingExpenses
|
1427092000 | |
CY2012 | us-gaap |
Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
|
300000 | |
CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
147264000 | |
CY2012 | md |
Line Of Credit Facility Payments For Amendment
LineOfCreditFacilityPaymentsForAmendment
|
2397000 | |
CY2012 | md |
Number Of Physician Group Practices
NumberOfPhysicianGroupPractices
|
16 | Company |
CY2012 | md |
Provision Adjustment For Losses Related To Current Year
ProvisionAdjustmentForLossesRelatedToCurrentYear
|
35441000 | |
CY2012 | md |
Health Care Organization Patient Service Revenue Gross
HealthCareOrganizationPatientServiceRevenueGross
|
5691790000 | |
CY2012 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
71823000 | |
CY2012 | md |
Hospital Contract Administrative Fees
HospitalContractAdministrativeFees
|
119746000 | |
CY2012 | md |
Payment Of Contingent Consideration Liability
PaymentOfContingentConsiderationLiability
|
786000 | |
CY2012 | md |
Decrease In Uncertain Tax Position
DecreaseInUncertainTaxPosition
|
3100000 | |
CY2012 | md |
Provision Adjustment For Losses Related To Prior Year
ProvisionAdjustmentForLossesRelatedToPriorYear
|
-8119000 | |
CY2012 | md |
Payments Of Contingent Consideration Liabilities
PaymentsOfContingentConsiderationLiabilities
|
9445000 | |
CY2012 | md |
Contractual Adjustments And Uncollectibles
ContractualAdjustmentsAndUncollectibles
|
3994924000 | |
CY2012 | md |
Net Change In Fair Value Of Contingent Consideration Liabilities
NetChangeInFairValueOfContingentConsiderationLiabilities
|
995000 | |
CY2012 | md |
Malpractice Loss Contingency Provision For Losses
MalpracticeLossContingencyProvisionForLosses
|
27322000 | |
CY2013Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.55 | |
CY2013Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
100784000 | shares |
CY2013Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.56 | |
CY2013Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
98618000 | shares |
CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
91552000 | |
CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
90765000 | |
CY2013Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
402000 | |
CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
55367000 | |
CY2013Q1 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
502715000 | |
CY2013Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
53318000 | |
CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
1189000 | |
CY2013Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
9144000 | |
CY2013Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
329201000 | |
CY2013Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
411163000 | |
CY2013Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
35398000 | |
CY2013Q1 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
19500000 | |
CY2012Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.49 | |
CY2012Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
98798000 | shares |
CY2012Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.50 | |
CY2012Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
96538000 | shares |
CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
79388000 | |
CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
79262000 | |
CY2012Q1 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
428000 | |
CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
48350000 | |
CY2012Q1 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
422616000 | |
CY2012Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
46869000 | |
CY2012Q1 | us-gaap |
Interest Expense
InterestExpense
|
554000 | |
CY2012Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7113000 | |
CY2012Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
272261000 | |
CY2012Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
343228000 | |
CY2012Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
30912000 | |
CY2012Q1 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
16985000 | |
CY2012Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.61 | |
CY2012Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99090000 | shares |
CY2012Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.62 | |
CY2012Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
97086000 | shares |
CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
99736000 | |
CY2012Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
99253000 | |
CY2012Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
365000 | |
CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
60544000 | |
CY2012Q2 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
449530000 | |
CY2012Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
48200000 | |
CY2012Q2 | us-gaap |
Interest Expense
InterestExpense
|
848000 | |
CY2012Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7687000 | |
CY2012Q2 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
275951000 | |
CY2012Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
349794000 | |
CY2012Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
38709000 | |
CY2012Q2 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
17956000 | |
CY2013Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.68 | |
CY2013Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
101098000 | shares |
CY2013Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.70 | |
CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99116000 | shares |
CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
113371000 | |
CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
112094000 | |
CY2013Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
396000 | |
CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
69218000 | |
CY2013Q2 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
529180000 | |
CY2013Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
54601000 | |
CY2013Q2 | us-gaap |
Interest Expense
InterestExpense
|
1673000 | |
CY2013Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
9870000 | |
CY2013Q2 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
331922000 | |
CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
415809000 | |
CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
42876000 | |
CY2013Q2 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
19416000 | |
CY2012Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.66 | |
CY2012Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
99618000 | shares |
CY2012Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.67 | |
CY2012Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
97876000 | shares |
CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
107373000 | |
CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
107171000 | |
CY2012Q3 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
422000 | |
CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
65910000 | |
CY2012Q3 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
473134000 | |
CY2012Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
48200000 | |
CY2012Q3 | us-gaap |
Interest Expense
InterestExpense
|
624000 | |
CY2012Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7925000 | |
CY2012Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
292030000 | |
CY2012Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
365761000 | |
CY2012Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
41261000 | |
CY2012Q3 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
17606000 | |
CY2013Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.76 | |
CY2013Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
101178000 | shares |
CY2013Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.77 | |
CY2013Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99506000 | shares |
CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
123291000 | |
CY2013Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
122156000 | |
CY2013Q3 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
372000 | |
CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
76958000 | |
CY2013Q3 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
554730000 | |
CY2013Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
54654000 | |
CY2013Q3 | us-gaap |
Interest Expense
InterestExpense
|
1507000 | |
CY2013Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
10461000 | |
CY2013Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
346879000 | |
CY2013Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
431439000 | |
CY2013Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
45198000 | |
CY2013Q3 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
19445000 | |
CY2012Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.66 | |
CY2012Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
100212000 | shares |
CY2012Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.67 | |
CY2012Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
98226000 | shares |
CY2012Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
103023000 | |
CY2012Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
102485000 | |
CY2012Q4 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
681000 | |
CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
66103000 | |
CY2012Q4 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
471332000 | |
CY2012Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
50271000 | |
CY2012Q4 | us-gaap |
Interest Expense
InterestExpense
|
1219000 | |
CY2012Q4 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8091000 | |
CY2012Q4 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
290671000 | |
CY2012Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
368309000 | |
CY2012Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
36382000 | |
CY2012Q4 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
19276000 | |
CY2013Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.78 | |
CY2013Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
101080000 | shares |
CY2013Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.79 | |
CY2013Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
99469000 | shares |
CY2013Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
123917000 | |
CY2013Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
123397000 | |
CY2013Q4 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
526000 | |
CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
78974000 | |
CY2013Q4 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
567387000 | |
CY2013Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
55636000 | |
CY2013Q4 | us-gaap |
Interest Expense
InterestExpense
|
1046000 | |
CY2013Q4 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
10491000 | |
CY2013Q4 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
353316000 | |
CY2013Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
443470000 | |
CY2013Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
44423000 | |
CY2013Q4 | md |
Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
|
24027000 |